High-Throughput Screening for Antibody Discovery Using Mirrorball Christyne Kane Senior Scientist I AbbVie Bioresearch Center
Antibody Engineering & Therapeutics December 12, 2017
Disclaimer
Christyne Kane is an employee of AbbVie.
Assessment of equipment is the opinion of the author.
AbbVie does not endorse any of the platforms described in this presentation.
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 2
Overview
Antibody Discovery:
Mirrorball HTS
Cell Killing Assay
Cell Surface Binding • Singleplex
•Multiplex
Isotype Determination: Bead Color Discrimination
ELISA Alternative: Bead Size Discrimination
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 3
Antibody Screening Assays
High-Throughput Screening for Antibody Discovery
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 4
• Soluble Target Binding • Cell Surface Antigen Binding • Species Cross-reactivity • Target Specificity • Functionality • Epitope Binning • Isotype
Use of Mirrorball Technology
Desired Antibody Properties
20-40
5 x 104
Numbers In
Viv
o An
tibod
y Di
scov
ery
Wor
kflo
w
5 x 107
Immunizations
Hybridoma Generation
(Fusion)
Screening
Sub-cloning
Purification & Characterization
Mirrorball Technology
• HOMOGENEOUS ASSAY - No wash steps
• Ability to MULTIPLEX for multiple antigens, cross-reactivity, or counter-screening
• Compatible with CONDITIONED MEDIA
• SENSITIVITY (adequate for low concentration supernatants)
• +/- HIT ASSESSMENT, flexible data analysis
• Integrates with AUTOMATION, miniaturization for HTS
• TIME SENSITIVE (24-hour turnaround)
• PLUG-AND-PLAY assay for multiple targets
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 5
Mirrorball Instrument
3 LED lasers • 405nm • 488nm • 640nm
4 Fluorescent Channels • FL-1 (420-488nm) • FL-2 (488-540nm) • FL-3 (560-610nm) • FL-4 (650-690nm)
1 Scatter Channel (SC-1)
Automation: Thermo Scientific Orbitor RS
Benefits of Mirrorball Mirrorball Instrument Configuration
Case Study: Target A
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 6
• TNF family member
• Transmembrane glycoprotein
• Forms a homotrimer
• Autoimmune indications
Desired Binding Properties
• Binding to specific epitope
• Binding to cell surface protein
Goal: To generate a panel of antibodies binding cell-surface Target A.
Target Biology
• Peptide immunizations in mice
Immunization Strategy
Membrane Extracellular
7μm Bead
Multiplexed Screening Enabled by Bead Size Discrimination
16μm Bead
Non-specific Antigen (optional)
Beads are Distinguishable
Specific Binding Detectable
Mix-and-Read Assay Setup
BV421 Anti-Species
Target-Specific Ab
Target Antigen
SA/Biotin
• 384 well plate format • No washing steps • Shorter incubation times • Smaller volumes of reagents • Multiplex-able
Compare to ELISA
16μm
bea
ds
7μm
bea
ds
BV421
Bead Size
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 7
Hybridoma HTS by Mirrorball Completely Correlates with ELISA
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 8
0.0 0.1 0.2 0.3 0.40
2000
4000
6000
0.4 0.5 0.6 0.7 0.8 0.9 1.0
Hit by Mirrorball& ELISAHit by neither
Mir
rorb
all
(Med
ian
FL2
Mea
n)Mirrorball vs. ELISA
ELISA(OD 450nm)
• Singleplex assay using 7μm beads
• No false positives • No false negatives
100% Correlation Threshold
Screening Methods are in Agreement for Hit Identification
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 9
Screening Assay Number of mAbs
Primary Screening (ELISA) 153
Secondary Screening
ELISA 38
Flow 38
Mirrorball 38
Binding to Target A
• Bead-based binding assay correlated with ELISA methods 100% for early supernatant screening.
• 8 antibodies identified bound specifically to Target A by flow cytometry.
Summary
0.01 0.1 1 10 100 10000.0
0.5
1.0
1.5
Binding to Target A Peptide (ELISA)
nM
OD
450
mAb 1mAb 2mAb 3mAb 4mAb 6mAb 7mAb 8
Neg. ControlmAb 5
0.0001 0.01 1 100 100000
50
100
150
200
Binding to Target A Cells (Flow)
nMGeo
Mea
n R
atio
TN
F-29
3H/w
t-29
3-H
mAb 1mAb 2mAb 3mAb 4mAb 6mAb 7mAb 8
Neg. ControlmAb 5
Case Study: Target B
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 10
• Soluble protein
• Neurology and cardiovascular indications
Desired Binding Properties
• Binding to target B protein
• +/- Binding to target protein family members
Goal: To generate a panel of antibodies binding Target B.
Target Biology
• Protein immunizations in mice
Immunization Strategy
Membrane Extracellular
Direct Isotype Determination Enabled by Sixplex Bead-based Assay
Mix-and-Read Assay Setup
sol-R2 sol-R3 sol-R4 sol-R5
SA/Biotin
Beads are Distinguishable
AF488
FL-4
sol-R
5
sol-R
4
sol-R
3
sol-R
2
Specific Binding Detectable
IgG2b IgG3 IgG2a IgG1
AF488 Anti-Species Light Chain
Anti- Species HC
Test Antibody
AF405/BV421 *LC-specificity
(optional)
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 11
HC & LC Isotypes are Clearly Detected in Hybridoma Supernatant
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 12
Kappa Lambda Antibody HC Isotype LC Isotype
mAb 1 IgG3 Kappa
mAb 2 IgG1 Kappa
mAb 3 IgG2a Kappa
mAb 4 IgG2a Kappa
mAb 5 IgG1 Lambda
mAb 6 IgG2a Kappa
mAb 7 IgG2a Kappa
mAb 8 IgG2a Kappa
mAb 9 IgG2a Kappa
mAb 10 IgG3 Kappa
Able to detect multiple isotypes per sample
IgG
2b
IgG
3
IgG
2a
IgG
1
IgG
2b
IgG
3
IgG
2a
IgG
1
IgG
2b
IgG
3
IgG
2a
IgG
1
IgG
2b
IgG
3
IgG
2a
IgG
1
IgG
2b
IgG
3
IgG
1
IgG
2b
IgG
3
IgG
2a
IgG
1
HT Isotype Determination Improves Upon Traditional ELISA
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 13
ELISA Isotyping Mirrorball Isotyping
Isotype Antibody Isotype
IgG2a mAb 1 IgG3
IgG2a mAb 2 IgG2a
IgG2a mAb 3 IgG2a
IgG2a mAb 4 IgG2a
IgG1 mAb 5 IgG3
IgG2a mAb 6 IgG2a
IgG2a mAb 7 IgG2a
IgG2a mAb 8 IgG2a
IgG2a mAb 9 IgG2a
IgG3 mAb 10 IgG3
0
0.5
1
IgG1 IgG2a IgG2b IgG3
OD
(450
nm)
0
0.5
1
IgG1 IgG2a IgG2b IgG3
OD
(450
nm)
Non-specific signals have potential to dilute or overpower specific signals, leading to incorrect isotype conclusions.
IgG
1
IgG
2a
IgG
2b
IgG
3
IgG
1
IgG
2a
IgG
2b
IgG
3
Specific signals are greater than all background levels, allowing for accurate determination of isotype results.
Case Study: Target C
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 14
• 7-Transmembrane GPCR with short extracellular loops.
• Small molecule antagonists and agonists are available.
• Unprecedented for targeting by biologics
NH2
COOH
M1
M2
M3
M4
M5
M6
EL1 EL2 EL3
Extr
acel
lula
r
M7
Mem
bran
e
Desired Binding Properties • Binding to cell surface • Cross reactivity to cyno • Cross reactivity to rat
Desired Biological Activity • Cell Killing
Goal: To generate a panel of antibodies binding cell surface Target C which can be internalized.
Target Biology
• cDNA immunizations in rats
Immunization Strategy
Singleplex Cell Binding Assay Enables HT Supernatant Screening
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 15
AF647 Anti-Species
Target - Expressing
Cell Line
(GFP+)
Target- Specific Ab Target
Antigen
GFP
AF647
Merge
GFP+ Cells are Detectable
Specific Binding Detectable
Mix-and-Read Assay Setup
(-) Binding (+) Binding AF647
GFP
Target C Campaign Enabled by Mirrorball Antibody Screening
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 16
Mirrorball Number of mAbs
Target C Species
Human 65
Cyno 59
Rat 39
Cell Killing 22/28 tested
Rat
nM0.000
10.0
01 0.01 0.1 1 10 10
010
000
2
4
6
8
10
GM
FI R
atio
(Tra
ns/W
T)
Cyno
nM0.000
10.0
01 0.01 0.1 1 10 10
010
000
5
10
15
GM
FI R
atio
(Tra
ns/W
T)
Human
nM
GM
FI R
atio
(Tra
ns/W
T)
0.000
10.0
01 0.01 0.1 1 10 10
010
000
5
10
15
20
Flow Cytometry Binding to Target C
Bio-activity
• Single-plex cell binding assay enabled all stages of supernatant screening.
• Antibodies identified bound specifically to Target C by flow cytometry and had a range of functional potencies.
Summary
Case Study: Target D
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 17
• TNF family member
• Transmembrane glycoprotein
• Forms a homotrimer
Desired Binding Properties • Binding to cell-surface protein • Cross-reactivity to Cyno
Desired Biological Activity • Block ligand/receptor interactions
Goal: To generate a panel of antibodies binding Target D which blocks interaction with receptor.
Target Biology
• Whole cell immunizations in mice
Immunization Strategy
Membrane Extracellular
Multiplexed Cell Binding Assay Enables HT Supernatant Screening
• 384 well plate format • No washing steps • Shorter incubation times • Smaller volumes of reagents • Fewer cells required • Multiplex-able
Cell Types are Distinguishable Mix-and-Read Assay Setup
AF488
Far Red
AF488 Anti-Species
Target- Expressing
Cell Line
Target- Specific Ab Target
Antigen
Parental Cell Line
100nM Far Red
1000nM Far Red
Compare to Flow Cytometry
Pare
ntal
Tran
sfec
ted
Specific Binding Detectable
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 18
Hybridoma HTS by Mirrorball: 89% Correlation with Flow Cytometry
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 19
0 20 40 60 80 1000
100
200
300
400
500
1000 2000 3000
500
1000
1500
2000Hit by Mirrorball& Flow CytometryHit by Flow Cytometry onlyHit by neither
Mir
rorb
all
(Tra
ns M
edia
n FL
2 M
ean/
WT
Med
ian
FL2
Mea
n)Mirrorball vs. Flow Cytometry
Flow Cytometry(GMFI Ratio: Trans/WT)
• Mirrorball missed 5/45 hits by Flow Cytometry (false negatives)
• No false positives
89% Correlation
Multiplexed Cell Binding Assay is Implemented for Sub-clone Screening
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 20
Binding & Blocking Assays
• Multiplexed cell binding assay demonstrated an 89% correlation with Flow cytometry methods.
• All downstream sub-clone screening was performed using the Mirrorball multiplexed cell binding assay, enabling the delivery of 8 antibodies.
Summary
0.0001 0.01 1 1000
200
400
600
800
Binding to Target D Cells
Conc. (nM)
GM
FI (T
rans
/WT)
mAb 1mAb 2mAb 3mAb 4mAb 5mAb 6mAb 7mAb 8Neg.Control
0.001 0.01 0.1 1 10 1000
20000
40000
60000
Target D Ligand Blocking (Flow)
Conc. (nM)
GM
FI
mAb 1
mAb 3mAb 4mAb 5mAb 6mAb 7mAb 8
mAb 2
Neg ControlPos Control
Screening Assay Number of mAbs
Primary Screening (Flow) 95
Secondary Screening
Flow 56
Blocking (Flow) 16
Case Study: Target E
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 21
• GPI-linked, glycosylated, membrane protein.
• Modulates T cell and macrophage activation.
• Oncology indications
Desired Binding Properties • Binding to cell surface target E • Cross-reactivity to Cyno • Cross-reactivity to Mouse
Desired Biological Activity • Internalization
Goal: To generate a panel of antibodies binding cell surface Target E which can be internalized.
Target Biology
• cDNA immunizations in mice
Immunization Strategy
GPI
GPI
Membrane Extracellular
High Throughput Cell Killing Assay
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 22
Detection Live Apoptotic* Dead
Hoechst Annexin V-AF488* TO-PRO-3
SMi Anti-Species Ab
Target- Expressing
Cell Line
Target- Specific Ab Target
Antigen
~72-96hrs *Optional
Mix-and-Read Assay Setup
Cells & Media Cells & Ab Complex
Well View
Target-specific Cell Killing is Detectable
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 23
Cell Killing
Conc. (nM)
% V
iabi
lity
0.000
10.0
01 0.01 0.1 1 10
0
20
40
60
80
100
Cells & Media
Neg. ControlAnti-Target C mAb
Example Data Plate View
100 - # Dead Cells + # Apoptotic Cells
# Total Cells
• Target-specific killing is detectable. • No non-specific killing is observed.
Summary % Viability =
Cell Killing Assay Enables HT Detection of Internalizing Antibodies
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 24
Platform Advantages • Compatible with early hybridoma screening. • Automated for high-throughput assay set-up and data reporting. • Streamlined process to identify functional leads.
0
20
40
60
80
100
Cell
Viab
ility
10% SN 2% SN 0.4% SN 0.08% SN
(+) (-) Hybridoma clones
Screening of Hybridoma Supernatants
Antibody Screening Assays: Saving Time, Labor & Reagents
Antibody Screening
Assays
ELISA Alternative: Bead Size Discrimination • Plug-and-play assay is easily established, requiring smaller amounts of reagents
and significantly less time, compared to traditional ELISA.
Isotype Determination: Bead Color Discrimination • Color-coded sol-R beads enable the establishment of a robust multiplex
assay able to identify 4-8 unique antibody properties with increased sensitivity compared to traditional methods.
• Format may be applied to cross-reactivity and specificity assays.
Cell Surface Binding • No wash assays require 1/10th the cells of traditional flow cytometry
screening and may be automated at all steps, including data processing.
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 25
Antibody Discovery: Mirrorball HTS
Cell Killing • High throughput cell killing assay allows for functional screening of hybridoma
supernatants using a small amount of material and a variety of secondary-conjugated toxins.
Acknowledgements
Amanda Horowitz Kwasi Ofori
Mary Abdalla Jane Seagal
William Stine
Julie Hugunin Shawn Jennings
Chung-Ming Hsieh
Diana Caracino Richard Kim Paul Wylie Ben Schenker Doug Mann Aline Cagwin Daniela Ionescu Jenny Buttaro Mirrorball Support
High-Throughput Screening for Antibody Discovery using Mirrorball | Date 12.12.17 | © 2017 26